COVID-19 cases rising across the U.S.
The U.S. is experiencing a COVID-19 resurgence as new cases increased 37% nationwide this week. Some 40% of Americans remain unvaccinated. Michael George reports.
Watch CBS News
The U.S. is experiencing a COVID-19 resurgence as new cases increased 37% nationwide this week. Some 40% of Americans remain unvaccinated. Michael George reports.
Health officials are identifying more cases of the Omicron variant in the U.S., though the Delta variant continues to be more dominant. Nikki Battiste has the latest.
The FDA has expanded authorization for Pfizer's COVID-19 vaccine booster for teens ages 16 and 17. Over 200 million people in the U.S. are now fully vaccinated, but the Omicron variant is raising concerns. CBS News' Bradley Blackburn reports. Then Dr. Jerry Abraham, director of vaccine programs at Kedren Health in Los Angeles, joins CBSN's Tanya Rivero from a vaccination clinic to discuss the latest.
The FDA authorized Pfizer's COVID booster shots for 16 and 17 year olds. The boosters had already been encouraged for adults. Nikki Battiste has the latest.
Less than a third of Americans 16 to 17 years old will initially be eligible to receive the additional dose.
The FDA may soon authorize Pfizer's COVID-19 vaccine booster shot for teens 16 and 17 years old. About a quarter of Americans eligible for the booster have received it. CBS News' Laura Podesta joins "CBSN AM" to discuss the latest in the fight against the coronavirus.
Some teenagers may soon be eligible for COVID-19 vaccine booster shots. This news comes after Pfizer revealed that three doses of its vaccine are more effective at neutralizing the Omicron variant than two. Dr. Esther Choo, professor of emergency medicine at Oregon Health and Sciences University, joins CBSN to discuss some of the latest coronavirus headlines.
Pfizer said early research found that two shots of its COVID vaccine appear to be much less effective against Omicron than previous variants, but a booster offers significantly more protection. Nikki Battiste has the latest.
Pfizer and BioNTech say a third dose of their COVID-19 vaccine is needed to fully protect against the Omicron variant. Recent studies show two doses of the shot are "significantly less effective at blocking the virus." John Moore, professor of microbiology and immunology at Weill Cornell Medical College, joins CBSN's Tanya Rivero to discuss the new variant and the latest vaccine information.
Pfizer says preliminary research shows that a booster dose of its existing COVID-19 vaccine raises effectiveness when battling the Omicron variant. CBS News' Laura Podesta joins "CBSN AM" with more.
Pfizer and BioNTech say research shows three doses of their COVID-19 vaccine is more effective at neutralizing the new Omicron variant than just two doses. The companies also revealed plans to develop a variant-specific shot by March. Urgent care nurse practitioner Justin Gill joins CBSN to discuss the latest coronavirus headlines.
While it appears that Omicron has a "very large" advantage over previous strains, it doesn't appear to be making people sicker, and Pfizer says a booster shot "neutralized" it in the lab.
New York City Mayor Bill de Blasio is setting new vaccine deadlines for private sector employees who work in-person, and children ages 5 to 11 who want to participate in certain indoor activities. Dr. Dyan Hes, founder of Gramercy Pediatrics. joins CBSN to discuss the latest coronavirus headlines.
The governor of New York announced five new confirmed cases of the Omicron COVID-19 variant after infections were detected in California, Minnesota and Colorado. Dr. Nada Fadul, an associate professor of infectious diseases at the University of Nebraska Medical Center, joins CBSN's Lana Zak to discuss the latest concerns with the new strain.
Health authorities in California have confirmed the first U.S. case of COVID-19 linked to the newly discovered Omicron variant. CBS News national consumer investigative correspondent Anna Werner reports on efforts to surveil for new cases of Omicron. Then, Dr. Adam Brown, an emergency physician and the COVID-19 task force chair at Envision Healthcare, joins CBSN's Lana Zak to discuss the latest.
Scientists in South Africa say they're starting to get an idea of how the Omicron coronavirus variant is affecting people, including increasing reinfections. Infectious disease specialist Dr. Amesh Adalja joins CBSN's Anne-Marie Green to discuss the new findings and his recommendations for how to protect yourself in public.
California sets new restrictions as coronavirus cases skyrocket; 5-year-old becomes "Santa's mailman" thanks to Make-a-Wish Foundation
COVID vaccine delivery begins in the U.S. as cases surge; 13-year-old battling rare cancer goes viral
FDA panel endorses Moderna vaccine for emergency use authorization; "Season of Giving": Teacher saves custodian's life with kidney donation
Pfizer's early data shows COVID-19 vaccine is more than 90% effective; Presidential election reveals a deeply divided nation
Record hospitalizations across the U.S. as daily cases top 100,000+ again; Young man becomes first person with Down syndrome to finish Ironman triathlon.
90-year-old woman becomes first to receive Pfizer COVID-19 vaccine in U.K.; Legendary pilot Chuck Yeager, first to break sound barrier, dies at 97
U.S. prepares for mass COVID-19 vaccine rollout as FDA weighs authorization; Secret Santa mails Christmas cash to essential workers
FDA panel recommends approval of Pfizer COVID-19 vaccine for emergency use; Andrea Bocelli and daughter starring in online Christmas concert
President Biden says while the Omicron variant is a cause for concern, it's not cause for panic. Speaking at the White House on Monday, Mr. Biden once again urged Americans to get vaccinated and to get their booster shots. CBS News senior White House and political correspondent Ed O'Keefe joins CBSN's Bradley Blackburn to discuss the Biden administration's response to the new variant and more.